Literature DB >> 36066412

Membrane Lipids Are an Integral Part of Transmembrane Allosteric Sites in GPCRs: A Case Study of Cannabinoid CB1 Receptor Bound to a Negative Allosteric Modulator, ORG27569, and Analogs.

Peter Obi1, Senthil Natesan1.   

Abstract

A growing number of G-protein-coupled receptor (GPCR) structures reveal novel transmembrane lipid-exposed allosteric sites. Ligands must first partition into the surrounding membrane and take lipid paths to these sites. Remarkably, a significant part of the bound ligands appears exposed to the membrane lipids. The experimental structures do not usually account for the surrounding lipids, and their apparent contribution to ligand access and binding is often overlooked and poorly understood. Using classical and enhanced molecular dynamics simulations, we show that membrane lipids are critical in the access and binding of ORG27569 and its analogs at the transmembrane site of cannabinoid CB1 receptor. The observed differences in the binding affinity and cooperativity arise from the functional groups that interact primarily with lipids. Our results demonstrate the significance of incorporating membrane lipids as an integral component of transmembrane sites for accurate characterization, binding-affinity calculations, and lead optimization in drug discovery.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 36066412      PMCID: PMC9512009          DOI: 10.1021/acs.jmedchem.2c00946

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   8.039


  80 in total

1.  Allosteric modulation of the cannabinoid CB1 receptor.

Authors:  Martin R Price; Gemma L Baillie; Adèle Thomas; Lesley A Stevenson; Morag Easson; Richard Goodwin; Adèle McLean; Lorraine McIntosh; Gillian Goodwin; Glenn Walker; Paul Westwood; Julia Marrs; Fiona Thomson; Phillip Cowley; Arthur Christopoulos; Roger G Pertwee; Ruth A Ross
Journal:  Mol Pharmacol       Date:  2005-08-19       Impact factor: 4.436

Review 2.  On the 'micro'-pharmacodynamic and pharmacokinetic mechanisms that contribute to long-lasting drug action.

Authors:  Georges Vauquelin
Journal:  Expert Opin Drug Discov       Date:  2015-07-13       Impact factor: 6.098

3.  Comparative Protein Structure Modeling Using MODELLER.

Authors:  Benjamin Webb; Andrej Sali
Journal:  Curr Protoc Bioinformatics       Date:  2016-06-20

4.  Empirical correlation between hydrophobic free energy and aqueous cavity surface area.

Authors:  J A Reynolds; D B Gilbert; C Tanford
Journal:  Proc Natl Acad Sci U S A       Date:  1974-08       Impact factor: 11.205

5.  Ligand-binding architecture of human CB2 cannabinoid receptor: evidence for receptor subtype-specific binding motif and modeling GPCR activation.

Authors:  Ying Pei; Richard W Mercier; Jenine K Anday; Ganesh A Thakur; Alexander M Zvonok; Dow Hurst; Patricia H Reggio; David R Janero; Alexandros Makriyannis
Journal:  Chem Biol       Date:  2008-11-24

6.  Endogenous vs Exogenous Allosteric Modulators in GPCRs: A dispute for shuttling CB1 among different membrane microenvironments.

Authors:  Mariano Stornaiuolo; Agostino Bruno; Lorenzo Botta; Giuseppe La Regina; Sandro Cosconati; Romano Silvestri; Luciana Marinelli; Ettore Novellino
Journal:  Sci Rep       Date:  2015-10-20       Impact factor: 4.379

Review 7.  Recent innovations in membrane-protein structural biology.

Authors:  James P Allen
Journal:  F1000Res       Date:  2019-02-22

8.  Automated builder and database of protein/membrane complexes for molecular dynamics simulations.

Authors:  Sunhwan Jo; Taehoon Kim; Wonpil Im
Journal:  PLoS One       Date:  2007-09-12       Impact factor: 3.240

Review 9.  Membrane Lipid Composition: Effect on Membrane and Organelle Structure, Function and Compartmentalization and Therapeutic Avenues.

Authors:  Doralicia Casares; Pablo V Escribá; Catalina Ana Rosselló
Journal:  Int J Mol Sci       Date:  2019-05-01       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.